The first stage of retinal signaling occurs when rods and cones absorb incoming light and change their electrical activity. That change provides an input for interconnected retinal neurons, which refine the signal before ganglion cells carry it through their axons toward the optic nerve. This sequence links photoreceptor responses with the organized output required for visual detection.
Rods and cones provide two photoreceptor populations that respond to incoming light and contribute to retinal signaling. Their activity supports visual capabilities including detection of form, color, movement, and changes in brightness. Evaluating these photoreceptor systems is clinically relevant when investigating photoreceptor degeneration, even though their individual contributions are not interchangeable in retinal assessment.
Interconnected retinal neurons refine the electrical information generated by photoreceptors before it reaches ganglion cells. Ganglion cell axons then transmit the processed output through the optic nerve. This intermediate processing matters because clinical impairment may arise within photoreceptors, retinal neural circuits, or the optic pathway, producing different points of failure along the visual signaling route.
Clinicians can combine electroretinography, fundus imaging, and visual field testing to investigate retinal performance. These assessments can reveal functional impairment and provide evidence relevant to photoreceptor degeneration, retinal vascular disease, or optic pathway damage. Their findings help support diagnosis and can also be used to monitor whether treatment outcomes correspond with changes in visual function.
Electroretinography is useful for detecting functional impairment within the visual signaling system. Because retinal function depends on photoreceptor activity and subsequent neural processing, abnormal findings can contribute to evaluation of conditions such as photoreceptor degeneration and retinal vascular disease. In clinical follow-up, electroretinography may also help monitor treatment outcomes alongside other retinal assessments.
Fundus imaging and visual field testing provide clinical evidence that complements functional assessment of the retina and visual pathway. Used with electroretinography, they can help identify impairment associated with retinal vascular disease, photoreceptor degeneration, or optic pathway damage. The combined information supports diagnosis and gives clinicians ways to track functional changes during treatment monitoring.